---
title: "Fresenius SE & Co. KGaA (FSNUY.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/FSNUY.US.md"
symbol: "FSNUY.US"
name: "Fresenius SE & Co. KGaA"
industry: "Health Care Services"
datetime: "2026-05-21T18:31:52.308Z"
locales:
  - [en](https://longbridge.com/en/quote/FSNUY.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/FSNUY.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/FSNUY.US.md)
---

# Fresenius SE & Co. KGaA (FSNUY.US)

## Company Overview

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [www.fresenius.com](https://www.fresenius.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:16.000Z

**Overall: B (0.39)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 3 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Large - The company has stable operations, allowing for dependable long-term returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 11.76% |  |
| Net Profit YoY | 277.86% |  |
| P/B Ratio | 1.18 |  |
| Dividend Ratio | 2.54% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 26652387947.64 |  |
| Revenue | 26849816278.53 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 7.73% | B |
| Profit Margin | 6.40% | B |
| Gross Margin | 26.38% | C |
| Revenue YoY | 11.76% | B |
| Net Profit YoY | 277.86% | A |
| Total Assets YoY | 3.82% | C |
| Net Assets YoY | 7.95% | B |
| Cash Flow Margin | 197.76% | B |
| OCF YoY | 11.76% | B |
| Turnover | 0.54 | C |
| Gearing Ratio | 51.70% | C |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Fresenius SE & Co. KGaA",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "11.76%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "277.86%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "1.18",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "2.54%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "26652387947.64",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "26849816278.53",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "7.73%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "6.40%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "26.38%",
          "rating": "C"
        },
        {
          "name": "Revenue YoY",
          "value": "11.76%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "277.86%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "3.82%",
          "rating": "C"
        },
        {
          "name": "Net Assets YoY",
          "value": "7.95%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "197.76%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "11.76%",
          "rating": "B"
        },
        {
          "name": "Turnover",
          "value": "0.54",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "51.70%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 15.52 | 8/87 | 59.39 | 25.23 | 23.71 |
| PB | 1.18 | 10/87 | 1.49 | 1.43 | 1.31 |
| PS (TTM) | 0.99 | 28/87 | 1.29 | 1.24 | 1.14 |
| Dividend Yield | 2.54% | 5/87 | 2.26% | 2.14% | 2.05% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-05-11T04:00:00.000Z

Total Analysts: **3**

| Rating | Count | Percentage |
|--------|-------|-----------| 
| Buy | 2 | 67% |
| Overweight | 1 | 33% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 12.08 |
| Highest Target | 16.80 |
| Lowest Target | 14.13 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/FSNUY.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/FSNUY.US/norm.md)
- [Related News](https://longbridge.com/en/quote/FSNUY.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/FSNUY.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**